Safety and Immunogenicity of HDT-301 Targeting a SARS-CoV-2 Variant Spike Protein

计划入组 48 人 · 首次发布于 2021 年 11 月 24 日

GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma

计划入组 100 人 · 首次发布于 2014 年 11 月 20 日

Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

计划入组 9 人 · 首次发布于 2014 年 10 月 31 日

acute flaccid myelitis RNA vaccine (HDT Bio)

HDT-201

HDT-211

CKD BIO CORPORATION

Italy

BELX BIO-PHARMACEUTICAL (TAIWAN) CORPORATION

Taiwan

CONMED PHARMACEUTICAL & BIO-MEDICAL CORPORATION

Taiwan

FDA Clears HDT Bio's First-in-Class HDT-321 for Crimean-Congo Hemorrhagic Fever Prevention

HDT Bio Launches Canadian Phase 1 Trial of HDT-401, a Locally Administered RNA Immune Activator for Glioblastoma

Wheeler Bio Partners with Mitsubishi Corporation to Expand AI-Enabled Biomanufacturing Platform Across Asia-Pacific